BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 18, 2021
View Archived Issues
Discovery and characterization of specific inhibitors of human mitochondrial transcription
Read More
Cellular underpinnings of allergen immunotherapy success
Read More
F8-4-1BBL, a novel antibody-cytokine fusion protein with potent antitumor activity in vivo
Read More
Presenilin mutations affect neuronal stem cells
Read More
New causal gene for chronic kidney disease
Read More
Trying to stay ahead of SARS-CoV-2 as variants emerge
Read More
Overactive immunity can increase susceptibility to fungal infections
Read More
With partner in crime, MYC repairs DNA breaks
Read More
Interim data from phase II studies of novel combination immunotherapy in pancreatic cancer
Read More
ViGeneron and Daiichi Sankyo collaborate to evaluate vgAAV for novel ophthalmic gene therapy
Read More
FDA approves Enhertu for previously treated HER2-positive gastric or GEJ cancer
Read More
CCS-1477, novel p300/CBP inhibitor with promising activity in prostate cancer
Read More
Metrion and LifeArc extend neuroscience drug discovery collaboration
Read More
Nanjing Sanhome Pharmaceutical patents PRMT5 inhibitors
Read More
Dosing begins in phase IIa study of STP-705 for cutaneous basal cell carcinoma
Read More
FDA approves Darzalex Faspro for newly diagnosed light-chain amyloidosis
Read More
SinoMab initiates phase I trial in China with SN-1011 for autoimmune disease
Read More
Novel anti-mesothelin and anti-FucGM1 ADCs show promising antitumor activity in vivo
Read More
EdiGene obtains IND approval in China for ET-01 for transfusion dependent beta-thalassemia
Read More
